OpenAI puts GPT-Rosalind behind a vetted-access program for biodefense builders

OpenAI's Rosalind Biodefense program sponsors access for vetted developers building tools for biodefense and pandemic preparedness. Its May 29, 2026 announcement centers on GPT-Rosalind, a gated model for life-sciences research.

The program aims to help teams turn research capabilities into defensive tools. A separate access expansion covers selected U.S. government and allied public-health partners. These are access and development pathways; the announcement does not establish a measured reduction in outbreaks or response times.